Feds Ask DEA to Reschedule Cannabis

Department of Health and Human Services (HHS) officials have recommended the Drug Enforcement Administration (DEA) place cannabis in Schedule III of the Controlled Substances Act (CSA).

They have released over 250 pages of documents along with a letter of recomendation to the administrator of the Drug Enforcement Administration stating (among other things) that cannabis “has a currently accepted medical use in treatment in the United States and a potential for abuse less than the drugs or other substances in Schedules I and II.”

Aside from whether it has a currently accepted medical use (CAMU), many states have already legalized cannabis for medical and recreational use. Knowing that most of the United States have medical cannabis programs which “have been in place for several years, and include features that actively monitor medical use and product quality characteristics of marijuana dispensed.”

The documents also discuss the factor of efficacy, stating the “review of the available information identified mixed findings of effectiveness across indications, ranging from data showing inconclusive findings to considerable evidence in favor of effectiveness, depending on the source.”

Next move to happen is when it hits the desk of DEA Administrator Milgram. A Biden appointee, perhaps fortunately.